Plant-based liquid formulation AAYUDH Advance steps-in to combat COVID-19

’AAYUDH Advance’ is recommended by hundreds of doctors and has been used successfully to treat over 50,000 patients.

With the second wave of COVID-19 pandemic wreaking havoc across the world, a breakthrough has been achieved to provide effective medical care and a treatment for COVID-19 patients.

’AAYUDH Advance’, a plant-based liquid formulation, has been found to be highly effective and safe in not one but two detailed human clinical trials conducted at two government hospitals in Ahmedabad. After just four days of treatment with ’AAYUDH Advance’, it successfully and effectively reduced the viral load in the patients, without any reported side effects.

All the COVID-19 patients that were treated with ‘AAYUDH Advance’ recovered (i.e. turned COVID Negative) and witnessed significant improvements in symptoms like body temperature, cough, and shortness of breath.

Furthermore, ‘AAYUDH Advance’ was found to be 3 times more effective than Remdesivir by Translational Health Science and Technology Institute (THSTI) – Department of Biotechnology, Government of India.

Made by Shukla AsharImpex Pvt. Ltd., in Gujarat, ’AAYUDH Advance’ is a liquid formulation comprising 21 different types of plant-based extracts. Ayurvedic scriptures report these ingredients to be effective and safe to be used for human consumption. These curative medicinal ingredients are processed using Quantum technology and Colloidal Sciences and are broken down to angstrom-sized (i.e. one-tenth of a nanometre) particles. This makes them far more effective.

Speaking about exceptional characteristics of the product, Mr. Deap Shukla, Managing Director, Shukla Ashar Impex Pvt. Ltd., said, “AAYUDH Advance starts where vaccines stop.” ‘AAYUDH Advance’ is different from vaccines: Vaccines help develop antibodies against particular strains of the virus. However, they are known not to provide 100% protection against the disease. In comparison, ‘AAYUDH Advance’ helps in the successful management of the disease when used concomitantly with the Standard recommended line of treatment.